BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23725561)

  • 21. [Not Available].
    Basset-Seguin N
    Ann Dermatol Venereol; 2018 Nov; 145 Suppl 5():VS36-VS41. PubMed ID: 30477683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTCH1 gene mutations in exon 17 and loss of heterozygosity on D9S180 microsatellite in sporadic and inherited human basal cell carcinomas.
    Santos DC; Zaphiropoulos PG; Neto CF; Pimentel ER; Sanches JA; Ruiz IR
    Int J Dermatol; 2011 Jul; 50(7):838-43. PubMed ID: 21699520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basal cell nevus syndrome showing several histologic types of Basal cell carcinoma.
    Go JW; Kim SH; Yi SY; Cho HK
    Ann Dermatol; 2011 Sep; 23 Suppl 1(Suppl 1):S36-40. PubMed ID: 22028568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of calretinin in odontogenic keratocysts and basal cell carcinomas: A study of sporadic and Gorlin-Goltz syndrome-related cases.
    Cesinaro AM; Burtini G; Maiorana A; Rossi G; Migaldi M
    Ann Diagn Pathol; 2020 Apr; 45():151472. PubMed ID: 31982676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel mutations in the PATCHED gene in basal cell nevus syndrome.
    Lam CW; Leung CY; Lee KC; Xie J; Lo FM; Au TS; Tong SF; Poon MK; Chan LY; Luk NM
    Mol Genet Metab; 2002 May; 76(1):57-61. PubMed ID: 12175781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elucidating the role of molecular signaling pathways in the tumorigenesis of basal cell carcinoma.
    Tang JY
    Semin Cutan Med Surg; 2011 Dec; 30(4 Suppl):S6-9. PubMed ID: 22177103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nevoid basal cell carcinoma syndrome (Gorlin syndrome).
    Lo Muzio L
    Orphanet J Rare Dis; 2008 Nov; 3():32. PubMed ID: 19032739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Odontogenic keratocysts in the Basal Cell Nevus (Gorlin-Goltz) Syndrome associated with paresthesia of the lower jaw: Case report, retrospective analysis of a representative Czech cohort and recommendations for the early diagnosis.
    Hubacek M; Kripnerova T; Nemcikova M; Krepelová A; Puchmajerova A; Malikova M; Havlovicová M; Cadova J; Kodet R; Macek M; Dostalova T
    Neuro Endocrinol Lett; 2016 Sep; 37(4):269-276. PubMed ID: 27857042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vismodegib for the treatment of basal cell carcinoma: results and implications of the ERIVANCE BCC trial.
    Dessinioti C; Plaka M; Stratigos AJ
    Future Oncol; 2014 May; 10(6):927-36. PubMed ID: 24941979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic profiling of basal cell carcinomas detects postzygotic mosaicism in basal cell naevus syndrome.
    Reinders MGHC; Cosgun B; Gijezen LMC; van Oosterhoud CN; Kelleners-Smeets NWJ; Vermander E; Vreeburg M; Steijlen PM; Mosterd K; van Geel M
    Br J Dermatol; 2019 Sep; 181(3):587-591. PubMed ID: 30520020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basal cell naevus syndrome: an update on genetics and treatment.
    John AM; Schwartz RA
    Br J Dermatol; 2016 Jan; 174(1):68-76. PubMed ID: 26409035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of basal cell carcinomas in patients with nevoid basal cell carcinoma syndrome.
    van der Geer S; Ostertag JU; Krekels GA
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):308-13. PubMed ID: 19207641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Germline mutations of the PTCH gene in Japanese patients with nevoid basal cell carcinoma syndrome.
    Minami M; Urano Y; Ishigami T; Tsuda H; Kusaka J; Arase S
    J Dermatol Sci; 2001 Sep; 27(1):21-6. PubMed ID: 11457640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTCH1 isoform 1b is the major transcript in the development of basal cell nevus syndrome.
    Gielen RCAM; Reinders MGHC; Koillinen HK; Paulussen ADC; Mosterd K; van Geel M
    J Hum Genet; 2018 Sep; 63(9):965-969. PubMed ID: 29930296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skeletal and cranio-facial signs in Gorlin syndrome from ancient Egypt to the modern age: sphenoid asymmetry in a patient with a novel PTCH1 mutation.
    Ponti G; Ruini C; Pastorino L; Loschi P; Pecchi A; Malagoli M; Mandel VD; Boano R; Conti A; Pellacani G; Tomasi A
    Future Oncol; 2014 May; 10(6):917-25. PubMed ID: 24941978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel mutation in the PTCH1 gene in a patient with Gorlin syndrome with prominent clinical features.
    Valdivielso-Ramos M; Solera J; Mauleon C; Hernanz JM; Amiñoso C; Galiano S; De la Cueva P
    Clin Exp Dermatol; 2014 Apr; 39(3):406-7. PubMed ID: 24635088
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical and genetic study in 22 patients with basal cell nevus syndrome].
    Pruvost-Balland C; Gorry P; Boutet N; Magnaldo T; Mamelle G; Margulis A; Kolb F; Duvillard P; Spatz A; Brugières L; Chompret A; Avril MF
    Ann Dermatol Venereol; 2006 Feb; 133(2):117-23. PubMed ID: 16508594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basaloid follicular hamartomas in pediatric Basal Cell Nevus Syndrome: A diagnostic challenge.
    Besagni F; Dika E; Ricci C; Misciali C; Veronesi G; Corti B; Gurioli C; Neri I
    J Dermatol; 2021 Jul; 48(7):1101-1105. PubMed ID: 34021633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials.
    Chang AL; Arron ST; Migden MR; Solomon JA; Yoo S; Day BM; McKenna EF; Sekulic A
    Orphanet J Rare Dis; 2016 Sep; 11(1):120. PubMed ID: 27581207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gorlin Syndrome.
    Palacios-Álvarez I; González-Sarmiento R; Fernández-López E
    Actas Dermosifiliogr (Engl Ed); 2018 Apr; 109(3):207-217. PubMed ID: 29373110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.